3644 results for «2773»

Filter By

3644 results

Management of bifurcation treatment in high-risk patients

22 May 2025 – From EuroPCR 2025

Explore advanced management strategies for bifurcation treatment in high-risk patients. This session presents techniques including circulatory-supported polymer-free angioplasty, management of spontaneous aorto-coronary dissection-induced cardiac arrest, and innovative reverse controlled balloon-crush methods, supported by challenging case studies.

Management of bifurcation treatment in high-risk patients

TAVI in bicuspid: all you need to know

22 May 2025 – From EuroPCR 2025

Understand the unique anatomical and clinical challenges of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valves. This session covers bicuspid valve epidemiology, indications for surgery and TAVI, and detailed discussion on sizing and deployment fundamentals specific to bicuspid anatomy to optimize procedural success.

TAVI in bicuspid: all you need to know

Acute complications during distal left main PCI - Part 2

22 May 2025 – From EuroPCR 2025

This session focuses on acute complications encountered during distal left main PCI. Review real-world challenging cases involving multiple unexpected complications, device retrieval techniques, fractured rota burr management during rota-tripsy, and strategies to navigate complex procedural challenges.

Acute complications during distal left main PCI - Part 2

Best companions's case on complications in calcified lesions: episode 2

22 May 2025 – From EuroPCR 2025

Join this session examining complex complications in calcified lesion interventions. Learn from cases featuring controversial approaches that successfully resolved issues, coronary perforation management, retrograde iatrogenic dissection after lithotripsy, and algorithmic bailout strategies essential for navigating challenging calcified lesion complications.

Best companions's case on complications in calcified lesions: episode 2

The role of DCB in non-left main true bifurcations

22 May 2025 – From EuroPCR 2025

This session offers a detailed exploration of drug-coated balloon (DCB) use in non-left main true bifurcation lesions. Learn to define suitable lesion characteristics for provisional stenting, understand stepwise procedural strategies minimizing implanted material, and appreciate the role of intravascular imaging in assessing bifurcation complexity and optimizing...

The role of DCB in non-left main true bifurcations

Managing TAVI-embolisation device

22 May 2025 – From EuroPCR 2025

Focus on managing TAVI device embolization in this specialized session. Discuss detailed techniques such as TAVI-in-TAVI procedures, addressing valve dysfunction, and innovative balloon-assisted retrieval methods for migrated transcatheter heart valves, emphasizing procedural nuances and bailout strategies.

Managing TAVI-embolisation device

PCI in a challenging coronary anatomy

22 May 2025 – From EuroPCR 2025

This session tackles PCI in challenging coronary anatomies, featuring cases with anomalous coronary arteries, complex access routes, and specialized stenting techniques. Learn from experiences managing dual anomalous arteries, navigating to difficult lesions, and applying innovative modified chimney stent methods to restore coronary flow.

PCI in a challenging coronary anatomy

Procedural aspects of DCB PCI

22 May 2025 – From EuroPCR 2025

Delve into procedural aspects of drug-coated balloon (DCB) PCI with a focus on lesion preparation, antiplatelet therapy, and outcomes in real-world settings. This session reviews the impact of pre-dilatation balloons on de novo lesions, compares ticagrelor versus clopidogrel post-PCI with drug-eluting balloons, and discusses streamlined revascularization...

Procedural aspects of DCB PCI

Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use

22 May 2025 – From EuroPCR 2025

Deep dive into pulmonary embolism catheter technologies through case-based presentations. Learn about established and novel devices for acute pulmonary embolism treatment, indications for device use, and management of procedural complications to optimize patient outcomes.

Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use

The calcium challenge: stent avoidance and in-stent restenosis treatment

22 May 2025 – From EuroPCR 2025

Confront the challenges posed by coronary calcium through innovative stent avoidance and in-stent restenosis treatment strategies. This session features analyses on the feasibility of intravascular lithotripsy (IVL) alone, its use prior to drug-coated balloon angioplasty, and in treating in-stent restenosis. Outcomes following IVL-assisted PCI are reviewed...

The calcium challenge: stent avoidance and in-stent restenosis treatment

Risk stratification of NSTEMI patients

22 May 2025 – From EuroPCR 2025

Explore the latest insights on risk stratification in NSTEMI patients through comparative analysis of established risk scores such as GRACE, HEART, and TIMI in predicting coronary artery disease severity. This session also reviews outcomes based on diabetes status and left ventricular ejection fraction, prospective validation of...

Risk stratification of NSTEMI patients

From evidence to practice: solving complex cases with EuroIntervention

22 May 2025 – From EuroPCR 2025

Translate evidence into clinical practice with this session focusing on complex case analyses supported by EuroIntervention resources. Experience detailed presentations of challenging PCI, intracoronary imaging, coronary physiology, and TAVI cases, each followed by evidence-based solutions provided through EuroIntervention. Enhance your decision-making skills by integrating guidelines and...

From evidence to practice: solving complex cases with EuroIntervention

Is DCB a new valid option for coronary revascularisation?

22 May 2025 – From EuroPCR 2025

This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...

Is DCB a new valid option for coronary revascularisation?

Bifurcation CAD: presentation and PCI strategies

22 May 2025 – From EuroPCR 2025

Navigate the complexities of coronary bifurcation disease with a comprehensive session covering decision-making, imaging applications, and PCI strategies. Review clinical scenarios involving left main disease, calcifications, and acute presentations. Understand the pivotal role of intracoronary imaging and explore provisional and two-stent techniques through detailed case discussions...

Bifurcation CAD: presentation and PCI strategies

Percutaneous And Non-fluoroscopic Procedures (PAN): promoting equality and radiation-free intervention

22 May 2025 – From EuroPCR 2025

Discover innovative non-fluoroscopic interventional techniques with the Percutaneous And Non-fluoroscopic Procedures (PAN) session. Learn how to perform radiation-free interventions using advanced technologies, assess their clinical equivalence to standard methods, and explore how these procedures may promote gender equality in interventional cardiology careers.

Percutaneous And Non-fluoroscopic Procedures (PAN): promoting equality and radiation-free intervention

When mitral disease is not the only problem on mitral TEER patients

22 May 2025 – From EuroPCR 2025

Explore the multifaceted challenges in patients undergoing mitral TEER when additional mitral and tricuspid pathologies coexist. This session reviews data from the EXPANDed studies on tricuspid regurgitation post-mitral TEER, one-year outcomes based on cardiac damage extent, pulmonary hypertension dynamics, and the long-term mortality causes in this...

When mitral disease is not the only problem on mitral TEER patients

Should STEMI treatment be related to specific clinical patient characteristics

22 May 2025 – From EuroPCR 2025

This session evaluates whether STEMI treatment should be tailored to specific clinical patient characteristics. It includes insights into STEMI management in very young patients, benefits of revascularisation of LAD non-culprit lesions in older AMI patients, clinical outcomes from the NAMI registry for young STEMI patients, and...

Should STEMI treatment be related to specific clinical patient characteristics

Understanding research: insights from a groundbreaking study

22 May 2025 – From EuroPCR 2025

Enhance your understanding of contemporary research in PCI versus CABG with this session. Learn foundational research principles, latest study findings, and how to translate evidence into clinical practice to improve patient communication and outcomes, bridging the gap between research and everyday cardiology care.

Understanding research: insights from a groundbreaking study

Difficult decision-making in left main revascularisation

22 May 2025 – From EuroPCR 2025

Address difficult clinical decisions in left main coronary artery revascularization through this session featuring complex cases. Topics include prioritization in combined left main, aortic valve disease, and low ejection fraction, management of myocardial infarction with severe mitral regurgitation and cardiogenic shock, and unique cases such as...

Difficult decision-making in left main revascularisation

High-risk PCI in acute coronary syndrome

22 May 2025 – From EuroPCR 2025

Explore high-risk PCI strategies in acute coronary syndrome patients who are unsuitable for surgery. This session presents insights on Killip class influence, haemodynamic support with micro-axial flow pumps, disease progression patterns in complicated STEMI, and the prognostic value of QFR-guided functional SYNTAX scores in ACS management.

High-risk PCI in acute coronary syndrome
Didn’t find what you were looking for?